Search

Showing "11155" results for ""

Hepatitis C virus can survive in syringes for up to 63 days

EuroSIDA study suggests tenofovir increases risk of chronic kidney disease

Studies confirm that drugs that penetrate brain control HIV better and improve symptoms of brain impairment

Antiretroviral drugs have variable effects on bones and fat, lipoatrophy uncommon with modern regimens

Many patients diagnosed with HIV today will have normal life expectancies, European studies find

Triglycerides linked to heart attack risk in D:A:D study

Successful hepatitis C treatment reduces HIV disease progression and non-liver-related mortality

Progression of atherosclerosis is linked to inflammation in people with HIV

HIV infection increases risk of bone fractures for men, but not for younger women

Gardasil highly effective at preventing pre-cancerous anal lesions in gay men

Kenya leads on circumcision rollout

FDA warns that saquinavir/ritonavir can cause heart rhythm disturbances

Missed opportunities for HIV testing of pregnant women

Bone fractures more likely in an HIV-positive cohort than in the general US population: HOPS study

H1N1 in people with HIV: severity of disease generally unaffected, vaccine responses may be blunted

CD4 counts declining more rapidly among recent seroconverters in US military cohort

Higher risk of neurocognitive problems in patients with lower CD4 nadirs

Suppressive antiretroviral therapy slows progression of atherosclerosis

Receive the latest HIV research and conference news

Showing "11155" results for ""

Hepatitis C virus can survive in syringes for up to 63 days

EuroSIDA study suggests tenofovir increases risk of chronic kidney disease

Studies confirm that drugs that penetrate brain control HIV better and improve symptoms of brain impairment

Antiretroviral drugs have variable effects on bones and fat, lipoatrophy uncommon with modern regimens

Many patients diagnosed with HIV today will have normal life expectancies, European studies find

Triglycerides linked to heart attack risk in D:A:D study

Successful hepatitis C treatment reduces HIV disease progression and non-liver-related mortality

Progression of atherosclerosis is linked to inflammation in people with HIV

HIV infection increases risk of bone fractures for men, but not for younger women

Gardasil highly effective at preventing pre-cancerous anal lesions in gay men

Kenya leads on circumcision rollout

FDA warns that saquinavir/ritonavir can cause heart rhythm disturbances

Missed opportunities for HIV testing of pregnant women

Bone fractures more likely in an HIV-positive cohort than in the general US population: HOPS study

H1N1 in people with HIV: severity of disease generally unaffected, vaccine responses may be blunted

CD4 counts declining more rapidly among recent seroconverters in US military cohort

Higher risk of neurocognitive problems in patients with lower CD4 nadirs

Suppressive antiretroviral therapy slows progression of atherosclerosis

Receive the latest HIV research and conference news